|
TCF20 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.64789999999427E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.459160E-03 |
| Normal-vs-Stage2 |
2.203400E-01 |
| Normal-vs-Stage3 |
6.15399999848165E-08 |
| Normal-vs-Stage4 |
4.08790001849013E-10 |
| Stage1-vs-Stage2 |
1.836590E-01 |
| Stage1-vs-Stage3 |
4.263600E-03 |
| Stage1-vs-Stage4 |
1.65005999999135E-05 |
| Stage2-vs-Stage3 |
8.862700E-03 |
| Stage2-vs-Stage4 |
4.752400E-04 |
| Stage3-vs-Stage4 |
1.059430E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.34700000000454E-05 |
| Normal-vs-AfricanAmerican |
5.517900E-03 |
| Normal-vs-Asian |
1.846860E-04 |
| Caucasian-vs-AfricanAmerican |
8.449200E-01 |
| Caucasian-vs-Asian |
5.647800E-01 |
| AfricanAmerican-vs-Asian |
8.401200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.43750000000254E-05 |
| Normal-vs-Female |
1.044400E-04 |
| Male-vs-Female |
3.645000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.675170E-03 |
| Normal-vs-Age(41-60Yrs) |
5.57259999999227E-05 |
| Normal-vs-Age(61-80Yrs) |
3.63820000004456E-06 |
| Normal-vs-Age(81-100Yrs) |
3.203000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.619400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.768200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.094200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.633600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.739200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.411200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.360740E-04 |
| Classical-VS-Follicular |
8.773800E-01 |
| Classical-VS-Other |
1.213770E-01 |
| Classical-VS-Normal |
2.826800E-04 |
| Tall-VS-Follicular |
2.101500E-03 |
| Tall-VS-Other |
9.819200E-01 |
| Tall-VS-Normal |
5.1342999962678E-08 |
| Follicular-VS-Other |
2.231800E-01 |
| Follicular-VS-Normal |
6.341600E-03 |
| Other-VS-Normal |
3.138900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.607400E-04 |
| Normal-vs-N1 |
2.60259999995682E-07 |
| N0-vs-N1 |
9.078300E-03 |
|
|
